Skip to main content
. 2021 Apr 1;11:629646. doi: 10.3389/fonc.2021.629646

Figure 5.

Figure 5

Pooled hazard ratio of survival. (A) meta-analysis of pooled hazard ratios of overall survival outcomes of anti–PD-1 versus anti–PD-L1 therapy, (B) overall survival of patients with immune checkpoint inhibitors using reconstructed survival data.